Holder of approval for placing drugs containing finasteride and dutysters are companies: Zentiva Ltd., Viatris Ltd., Generic Pharma Gesellschaft Mbh, Alpha-Medical Ltd., Belupo DD, PharmaS doo, Galenika International Kft., Glaxosmithkine Trading Services LIMITED, ALKALOID-INT DOO, PLIVA Hrvatska doo, MIP PHARMA CROATIA doo I ORGANON Pharma doo
Croatian Medicines Agency (HALMED) and 13 pharmaceutical companies in cooperation with the European Medicine Agency sent a letter to health workers to reduce the risk of suicidal thoughts related to Dutasteride and FinasterID, Croatian media transmitted
Holder of approval for placing drugs containing finasteride and dutysters are companies: Zentiva Ltd., Viatris Ltd., Generic Pharma Gesellschaft Mbh, Alpha-Medical Ltd., Belupo DD, PharmaS doo, Galenika International Kft., Glaxosmithkine Trading Services LIMITED, ALKALOID-INT DOO, PLIVA Hrvatska doo, MIP PHARMA CROATIA doo I ORGANON Pharma doo
Drugs containing a finasteride in the form of a 1 mg tablet or skin application are used in the treatment of early androgenic alopecial stages (hair loss associated with male sex hormones). In Croatia, such medications were not approved. However, medications containing a finasteride in the form of a 5 mg tablet and a 0.5 mg dutasteride are applied in the treatment of Benigna hyperplasia (BHP) and are approved in the Republic of Croatia.
Suicidal thoughts are the side effect of oral drugs containing finasteride, and are most often recorded in patients treated because of androgenic alopecia. Patients treating oral finasteride due to androgenic alopecia should be advised to stop treatment and search for medical advice if they feel depressed mood, depression, or thinking of suicide.
Sexual dysfunction that can contribute to changes in moods, including suicidal thoughts, has been reported in some patients treated due to androgenic alopecia. Patients should be advised to address the doctor in case they experience sexual dysfunction and consider cessation of treatment. Although there is insufficient evidence of direct connection to suicidal thoughts, due to the joint function of all 5-alpha-reduct inhibitors, it is recommended that patients taking Dutasteride are searching for medical advice if you notice the symptoms of mood swings, Transfers N1.
